Greenline Wealth Management’s Transmedics TMDX Stock Holding History

Greenline Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-99	Closed	-$12.1K	–	476
2025 Q4	$12.1K	Buy	+99	New	+$12.4K	0.01%	325

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenline Wealth Management's TMDX Position: Q1 2026 in Review

Greenline Wealth Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 99 shares — an estimated $12.1K sold.

Greenline Wealth Management first reported a position in TMDX in Q4 2025 and held it in 1 quarter. The position peaked at $12.1K in Q4 2025. 416 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Greenline Wealth Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Greenline Wealth Management sold 99 Transmedics shares in Q1 2026, an estimated $12.1K.
Greenline Wealth Management first reported a position in Transmedics in Q4 2025 and held it in 1 quarter.
Greenline Wealth Management's Transmedics position peaked at $12.1K in Q4 2025.
416 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Greenline Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.